Definium Therapeutics, Inc.

NASDAQ:DFTX

Biotechnology

Healthcare
$29.38 -1.67%

-$0.41 today

Market cap
$4.02B
Beta
2.38
P/E (TTM)
-11.0
EPS (TTM)
-$2.18
52W Low $12.88High $26.15

Volume 1.92M

Average 2.67M

Fair Value & DCF

Compare our fair value with your own assumptions

Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.

Definium Therapeutics, Inc.

NASDAQ:DFTX

Intrinsic Alpha fair value

Locked

Current Price

$29.38

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.

Build your own valuation

Test an independent scenario and compare it with Intrinsic Alpha's estimate.

Sign in to use the DCF calculator

Free accounts get 5 valuations per week. Upgrade for more.

Sign in / Sign up

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A4 analysts
RevenueN/AN/AN/A
N/A6 analysts
Net IncomeN/AN/AN/A
N/A6 analysts
EBITN/AN/AN/A
N/A6 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Estimates & History

Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.

Further estimates hidden. Sign in to unlock

Competitor Valuations

Peer stocks ranked by intrinsic value status

CompanyMarket CapPriceValuationP/E1Y Return

Praxis Precision Medicines, Inc.

NASDAQ:PRAX

$9.17B$328.13Not rated-25.0+65.68%

Axsome Therapeutics, Inc.

NASDAQ:AXSM

$7.45B$141.69Not rated-68.6-7.82%

LB Pharmaceuticals Inc Common Stock

NASDAQ:LBRX

$1.39B$43.01Not rated-21.4+153.14%

GH Research PLC

NASDAQ:GHRS

$1.31B$19.10Not rated-23.8+32.87%

Rapport Therapeutics, Inc. Common Stock

NASDAQ:RAPP

$1.25B$26.15Not rated-16.2-6.16%

Alto Neuroscience, Inc.

NYSE:ANRO

$1.18B$29.54Not rated-9.8+68.88%

MapLight Therapeutics, Inc.

NASDAQ:MPLT

$308.98M$7.25Not rated-2.8-55.82%

Minerva Neurosciences, Inc.

NASDAQ:NERV

$114.62M$2.30Not rated-0.2-49.77%

Neumora Therapeutics, Inc. Common Stock

NASDAQ:NMRA

$80.59M$0.43Not rated-1.2-87.42%

Alterity Therapeutics Limited

NASDAQ:ATHE

$33.20M$1.96Not rated-9.9-13.47%